Insight Molecular DiagnosticIMDX
13F holders, Q1 2024 (March 31)23holders
1famous investor
$2.93avg. 13F price*
At the end of Q1 2024, 23 institutions reported holding Insight Molecular Diagnostic (IMDX) in their 13F filings. The largest holders were Broadwood Capital Inc. ($7.4M), Pura Vida Investments, LLC ($1.5M) and Vanguard Group Inc. ($726K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Insight Molecular Diagnostic
- Filed as
- ONCOCYTE CORP (Q1 2024)
- CUSIP
- 68235C206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1K |
| Exits | 1 | $10 |
Ownership 23 holders
| Broadwood Capital Inc. | 0.55% | No change | 2,509,066 | $7.4M |
| Pura Vida Investments, LLC | 1.05% | Reduce -10.7% | 523,928 | $1.5M |
| Vanguard Group Inc. | 0.00% | No change | 247,873 | $726K |
| Morgan Stanley | 0.00% | Add +0.2% | 123,211 | $361K |
| Geode Capital Management, LLC | 0.00% | Add +1.6% | 62,433 | $183K |
| BlackRock Inc. | 0.00% | No change | 60,187 | $176K |
| State Street Corp. | 0.00% | No change | 16,289 | $48K |
| Renaissance Technologies | 0.00% | Reduce -3.9% | 12,218 | $36K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -43.5% | 1,880 | $6K |
| UBS Group AG | 0.00% | Reduce -37.4% | 864 | $3K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 500 | $1K |
| Lanark Financial, Inc. | 0.00% | New | 150 | $1K |
| Bank of America Corp. | 0.00% | Reduce -2.8% | 210 | $615 |
| JPMorgan Chase & Co. | 0.00% | No change | 154 | $451 |
| Osaic Holdings, Inc. | 0.00% | No change | 97 | $284 |
| Wells Fargo & Company | 0.00% | Add +1.7% | 61 | $179 |
| Riggs Asset Managment Co. Inc. | 0.00% | No change | 50 | $147 |
| Piscataqua Savings Bank | 0.00% | No change | 25 | $73 |
| Comerica Bank | 0.00% | Reduce -4.2% | 23 | $67 |
| FMR LLC | 0.00% | New | 13 | $38 |
| Albion Financial Group | 0.00% | No change | 7 | $21 |
| Qube Research & Technologies Ltd | 0.00% | No change | 1 | $3 |
| Royal Bank of Canada | 0.00% | Reduce -91.1% | 80 | $0 |
"% of holder's portfolio" is IMDX's weight in each manager's 13F, not the share of Insight Molecular Diagnostic the manager owns.